Cite
Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process
MLA
Manon M.J. Cox, et al. “Technology Transfer and Scale-up of the Flublok® Recombinant Hemagglutinin (HA) Influenza Vaccine Manufacturing Process.” Vaccine, vol. 32, Sept. 2014, pp. 5496–502. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....17953b9bbed9632bf513e57efb5afd64&authtype=sso&custid=ns315887.
APA
Manon M.J. Cox, Clifton McPherson, Barry Buckland, Mireli Fino, Kathy Holtz, Indresh K. Srivastava, Paul Kubera, Nikolai Khramtsov, Jamal Meghrous, & Robert Boulanger. (2014). Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process. Vaccine, 32, 5496–5502.
Chicago
Manon M.J. Cox, Clifton McPherson, Barry Buckland, Mireli Fino, Kathy Holtz, Indresh K. Srivastava, Paul Kubera, Nikolai Khramtsov, Jamal Meghrous, and Robert Boulanger. 2014. “Technology Transfer and Scale-up of the Flublok® Recombinant Hemagglutinin (HA) Influenza Vaccine Manufacturing Process.” Vaccine 32 (September): 5496–5502. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....17953b9bbed9632bf513e57efb5afd64&authtype=sso&custid=ns315887.